Knowledge Enhancing and Enabling Platform (KEEP), is a comprehensive Solution for generating and integrating knowledge from clinical trials.

KEEP Enterprise

Clinical Databases Platform

Knowledge Enhancing and Enabling Platform to support...
Optimize dose, dose regimen & trial design
Facilitate early go/no go decisions
Portfolio prioritization
Marketing viability and market strategy

The KEEP aims to integrate and enhance clinical knowledge and enable model-based meta-analysis (MBMA).

clinical knowledge, enable model-based meta-analysis (MBMA)
securely access, share, explore, analyze, comprehensive, integrated, up-to-date, clinical efficacy, safety, drug development

It provides the capability to quickly and securely access, share, explore, and analyze comprehensive, integrated, up-to-date clinical efficacy and safety data to facilitate effective drug development.

WHAT IS KEEP?

KNOWLEDGE REPOSITORY OF CLINICAL TRIAL DATA

  • Most current publicly available trial data

  • Design, patient, and treatment characteristics

  • Biomarker, efficacy, and safety outcomes

  • Internal CSRs, patient level data (optional)

EXPLORATORY ANALYSIS PLATFORM

  • Multi-variable filtering and summary tables

  • Comparative time course plots

COMMUNICATION TOOL

  • Makes data tangible and accessible – interact, plot, summarize, in real time

  • Maps the competitive landscape - navigate competitor information

  • Stimulates ideas for impactful analysis

WHY KEEP?

ACCESS MULTIPLE DATABASES ON ONE PLATFORM

  • Cardiovascular, CNS, immunology, infectious diseases, oncology, metabolic diseases, pain

  • Literature databases as well as internal CSRs

COMMUNICATE CURRENT KNOWLEDGE FROM CLINICAL TRIALS

  • Present up-to-date data in a user-friendly web-based interface

  • Illustrate between-trial variability for a multitude of interventions and endpoints

FACILITATE MODEL-BASED META-ANALYSIS

  • Facilitating early go/no go decisions

  • Optimizing dose selections and study designs

  • Quantitative analysis of comparative efficacy and safety of competitive interventions

BioITWorld-logo.png

2021
Boston, MA

page2_edited.png

2021

Ljubljana, Slovenia

acop.jpg

November 9th - 13th, 2020

Virtual